Search Results

EvoEndo®, Inc. announces that Duke Health is the first provider in the region to bring Sedation-Free TNE of the Upper Gastrointestinal Tract using the EvoEndo® Single-Use Endoscopy System to patients in North Carolina.

Immunovia announces that the company will move its lab and U.S. headquarters to Research Triangle Park in North Carolina in May 2024.

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, announced two supply contracts that mark its strategic expansion into the East and Southeast Asian region.

The Department of Health – Abu Dhabi, the regulator of the healthcare sector in the Emirate, signed a Memorandum of Understanding with Roche Pharmaceuticals Middle East during Abu Dhabi Global Healthcare Week.

Aurinia Pharmaceuticals Inc., announced the presentation of two studies at the annual Congress of Clinical Rheumatology East 2024 taking place in Destin, FL, May 9-12.

Merz Therapeutics announced today its U.S. organization has made a $100,000 donation to the University of North Carolina (UNC) Health Foundation

Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company developing novel, investigational engineered cytokine therapies designed to address areas of unmet need for patients with a variety of cancers, today announced that Caroline Loew, Ph.D., CEO, will present at the East Coast IDEAS Investor Conference on June 13 at 9:15 a.m. EST.

Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.

The global contract development and manufacturing organization is investing $1.2 billion to boost production capabilities at its Holly Springs, North Carolina, site including mammalian cell culture bioreactors.